FLOW Trial: Fluoxetine to Open the Critical Period Time Window to Improve Motor Recovery After Stroke
Phase of Trial: Phase II
Latest Information Update: 21 Aug 2019
Price : $35 *
At a glance
- Drugs Fluoxetine (Primary)
- Indications Paresis; Stroke complications
- Focus Therapeutic Use
- Acronyms FLOW
- 22 Mar 2019 Planned End Date changed from 31 Dec 2020 to 30 Sep 2020.
- 22 Mar 2019 Planned primary completion date changed from 31 Dec 2020 to 30 Sep 2020.
- 22 Mar 2019 Status changed from not yet recruiting to recruiting.